Shankar S, Gulati M, Kang M, Gupta S, Suri S
Department of Radiodiagnosis and Imaging, PGIMER, Chandigarh, India.
Eur Radiol. 2000;10(3):495-9. doi: 10.1007/s003300050083.
The aim of this study was to assess the safety and efficacy of image-guided percutaneous catheter drainage (IGPCD) of thoracic empyemas, and to correlate the outcome of IGPCD with the pre-procedural sonographic appearance. One hundred three patients (74 males and 29 females) with thoracic empyema (age range 1 month to 70 years, median age 28 years) underwent IGPCD. In 63 (61.17%) patients, IGPCD was the primary treatment modality; in 40 (38.84%) patients it was used after unsuccessful intercostal chest tube drainage (ICTD). Ultrasound was the main modality used for guidance; CT guidance was used in only 7 patients (6.8%). Eight- to 12-F pigtail catheters or 10- to 14-F Malecot catheters were used. The outcome was correlated with the pre-procedural US appearance (anechoic, complex non-septated or complex septated) of the empyema. The IGPCD technique was successful in 80 of 102 patients. Based on the US appearance, IGPCD was successful in 12 of 13 (92.3%) patients with anechoic empyemas; 53 of 65 (81.54%) patients with complex non-septated empyemas, and in 15 of 24 (62.5%) patients with complex septated empyemas. A statistically significant difference (p < 0.01) was seen in the outcome of IGPCD in the three categories. Twenty-two patients required further treatment: ICTD (n = 9; 2 of them later also underwent surgery); and surgery (n = 15). The duration of catheter drainage ranged from 2-60 days. No major complications were encountered. Percutaneous catheter drainage of thoracic empyemas with imaging guidance ensures accurate catheter placement with a high success and a low complication rate. Pre-procedural US can predict the likelihood of success of IGPCD.
本研究的目的是评估影像引导下经皮导管引流术(IGPCD)治疗胸腔积脓的安全性和有效性,并将IGPCD的治疗结果与术前超声表现相关联。103例胸腔积脓患者(男性74例,女性29例)接受了IGPCD治疗(年龄范围1个月至70岁,中位年龄28岁)。63例(61.17%)患者中,IGPCD是主要治疗方式;40例(38.84%)患者在肋间胸腔闭式引流(ICTD)失败后使用。超声是主要的引导方式;仅7例(6.8%)患者使用了CT引导。使用了8至12F猪尾导管或10至14F马勒科特导管。将治疗结果与胸腔积脓术前超声表现(无回声、复杂无分隔或复杂有分隔)相关联。102例患者中80例IGPCD技术成功。根据超声表现,13例无回声胸腔积脓患者中有12例(92.3%)IGPCD成功;65例复杂无分隔胸腔积脓患者中有53例(81.54%)成功,24例复杂有分隔胸腔积脓患者中有15例(62.5%)成功。在这三类患者中,IGPCD的治疗结果存在统计学显著差异(p<0.01)。22例患者需要进一步治疗:ICTD(9例;其中2例后来也接受了手术);手术(15例)。导管引流持续时间为2至60天。未出现重大并发症。影像引导下经皮导管引流胸腔积脓可确保导管准确放置,成功率高且并发症发生率低。术前超声可预测IGPCD成功的可能性。